AKBA vs CLOV
Akebia Ther (AKBA) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AKBA revenue for 2024-12-31 was $160.2M. Net income was -$69.4M. Revenue was down 17.7% from 2023-12-31 to 2024-12-31. AKBA currently screens at market cap $260.1M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AKBA currently screens at market cap $260.1M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AKBA and CLOV stock pages for the full models.
Not investment advice.